The Silence Therapeutics acquisition gives Merck KGaA a drug ready for a pivotal test in the blood disorder polycythemia vera ...

AdvaMed CEO Scott Whitaker outlined four policy priorities at the MedTech Conference: tariffs, FDA user fees, payment and coverage, and cybersecurity.

Some of the thorniest problems in medicine that AI can improve have nothing to do with diagnosis. They have to do with triage ...

GLP-1 drugs first made their mark in diabetes and obesity, but many research efforts are underway to bring such therapies to more indications. Altimmune now has mid-stage clinical trial results ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The ...

HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy.

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems ...

Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record.

Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say ...

Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or ...

Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah ...